Report / Paper metadata
Preoperative mFOLFIRINOX versus PAXG for stage I-III resectable and borderline resectable pancreatic ductal adenocarcinoma (PACT-21 CASSANDRA): results of the first randomisation analysis of a randomised, open-label, 2 × 2 factorial phase 3 trial.
A biomedical paper record. This page preserves its title, publication metadata and identifier, not the full article. The title alone does not establish the study findings or their clinical importance.
Source and limits
Source: PubMed. Stored source metadata; check the linked original before acting.
Bibliographic/status field selection only; abstracts, full text, contact fields and unselected fields omitted. No clinical interpretation.
No clinical review has been performed. This record is not a treatment recommendation, eligibility confirmation or current availability guarantee.
- Identifier
- PMID 41275879
- Journal
- Lancet (London, England)
- Kind
- Paper metadata